Alopecia Diffusa while Using Interleukin-17 Inhibitors against Psoriasis Vulgaris
Open Access
- 28 March 2019
- journal article
- research article
- Published by S. Karger AG in Case Reports in Dermatology
- Vol. 11 (1) , 82-85
Abstract
We report two cases of alopecia diffusa during the treatment of psoriasis vulgaris with interleukin (IL)-17 inhibitors. Psoriasis is one of the most common immune-mediated chronic skin diseases, strongly associated with IL-17A. Clinically, the monoclonal antibodies to IL-17A or its receptor, IL-17R, show a dramatic effect against psoriasis. Alopecia is also an IL-17-mediated autoimmune disease, and IL-17 inhibitors have been expected to be the gold standard for the treatment of alopecia; therefore, the complication of alopecia while using IL-17 may be regarded as an unexpected “paradoxical reaction.” T helper (Th)17 cells are not cytotoxic enough by themselves to undermine the hair follicle under normal circumstances, they need the coexistence of CD8+ cytotoxic Th1 cells. Th17 cells may be the initiator of the damage of the hair follicle, but CD8 T cells or more powerful Th1 cells are required as followers. The Th17/Th1 axis might convert into a Th1-dominant immune status using IL-17 inhibitors, and the destruction of the hair follicle might result in alopecia. An accumulation of cases is to be expected.Keywords
This publication has 4 references indexed in Scilit:
- IL-17 inhibition: is it the long-awaited savior for alopecia areata?Archives of Dermatological Research, 2018
- Interleukin‐17+CD8+ T Cells Are Enriched in the Joints of Patients With Psoriatic Arthritis and Correlate With Disease Activity and Joint Damage ProgressionArthritis & Rheumatology, 2014
- Comparison of Interleukin-17- Producing Cells in Different Clinical Types of Alopecia AreataDermatology, 2013
- Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatmentAnnals of the Rheumatic Diseases, 2006